Laponis reported that DNA synthesis and protein solutions (DSPS) revenue increased to $51.1 million , up 27% year over year , and said the growth was driven by customers pursuing AI-enabled discovery. Leproust said the company had booked more than $25 million in orders tied specifically to AI discovery in fiscal 2025, describing those orders as “backloaded,” with some orders received in the fourth quarter shipping in the first quarter. In response to analyst questions, she said customers with large orders i ...